Reuters - Bristol-Myers Squibb Co said on Thursday its liver cancer drug brivanib failed to meet the primary endpoint in a late-stage clinical trial.
You are here:
Health 
Diseases & Conditions Bristol-Myers liver cancer drug fails trial
(Reuters)
Diseases & Conditions Bristol-Myers liver cancer drug fails trial
(Reuters)
